These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23283741)

  • 1. Comparison of antibiotic resistance patterns in collections of Escherichia coli and Proteus mirabilis uropathogenic strains.
    Adamus-Bialek W; Zajac E; Parniewski P; Kaca W
    Mol Biol Rep; 2013 Apr; 40(4):3429-35. PubMed ID: 23283741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal relatedness of Proteus mirabilis strains causing urinary tract infections in companion animals and humans.
    Marques C; Belas A; Aboim C; Trigueiro G; Cavaco-Silva P; Gama LT; Pomba C
    Vet Microbiol; 2019 Jan; 228():77-82. PubMed ID: 30593384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection.
    Alteri CJ; Himpsl SD; Mobley HL
    PLoS Pathog; 2015 Jan; 11(1):e1004601. PubMed ID: 25568946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection.
    Zhao H; Thompson RB; Lockatell V; Johnson DE; Mobley HL
    Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of inflammatory cytokine expression in the urinary tract of BALB/c mice infected with Proteus (P.) mirabilis and enteroaggregative Escherichia (E.) coli (EAEC) strains.
    Melendez-Avalos A; Sainz-Espuñes T; Castrillón-Rivera LE; Mendoza-Pérez F; Palma-Ramos A; Castañeda-Sánchez JI; Drago-Serrano EM
    Folia Microbiol (Praha); 2020 Feb; 65(1):133-142. PubMed ID: 31104302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
    Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL
    Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016).
    Zanichelli V; Huttner A; Harbarth S; Kronenberg A; Huttner B; Swiss Centre For Antibiotic Resistance Anresis
    Swiss Med Wkly; 2019 Jul; 149():w20110. PubMed ID: 31340052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.
    Girlich D; Bonnin RA; Bogaerts P; De Laveleye M; Huang DT; Dortet L; Glaser P; Glupczynski Y; Naas T
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
    Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL
    Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation].
    Cernohorská L; Chvílová E
    Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):81-5. PubMed ID: 21780025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
    Li X; Johnson DE; Mobley HL
    Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indwelling Urinary Catheter Model of Proteus mirabilis Infection.
    Smith SN; Armbruster CE
    Methods Mol Biol; 2019; 2021():187-200. PubMed ID: 31309506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vero cell invasiveness of Proteus mirabilis.
    Peerbooms PG; Verweij AM; MacLaren DM
    Infect Immun; 1984 Mar; 43(3):1068-71. PubMed ID: 6365782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
    Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
    Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterisation of dog uropathogenic Proteus mirabilis strains.
    Gaastra W; van Oosterom RA; Pieters EW; Bergmans HE; van Dijk L; Agnes A; ter Huurne HM
    Vet Microbiol; 1996 Jan; 48(1-2):57-71. PubMed ID: 8701578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence genes and antimicrobial resistance pattern in Proteus mirabilis strains isolated from patients attended with urinary infections to Tertiary Hospitals, in Iran.
    Tabatabaei A; Ahmadi K; Shabestari AN; Khosravi N; Badamchi A
    Afr Health Sci; 2021 Dec; 21(4):1677-1684. PubMed ID: 35283944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
    Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
    Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan.
    Nakamura T; Komatsu M; Yamasaki K; Fukuda S; Miyamoto Y; Higuchi T; Ono T; Nishio H; Sueyoshi N; Kida K; Satoh K; Toda H; Toyokawa M; Nishi I; Sakamoto M; Akagi M; Nakai I; Kofuku T; Orita T; Wada Y; Zikimoto T; Koike C; Kinoshita S; Hirai I; Takahashi H; Matsuura N; Yamamoto Y
    Am J Clin Pathol; 2012 Apr; 137(4):620-6. PubMed ID: 22431539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.